US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 31.490
  • +0.280+0.90%
Close Feb 27 16:00 ET
  • 27.640
  • -3.850-12.23%
Post 16:44 ET
1.51BMarket Cap10.46P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Amphastar Pharmaceuticals Q4 2024 Estimates Date

Currency:USDFeb 27, 2025

Estimate YoY
Revenue
188.78M
+5.99%
EPS
0.78
--
Buy

Feb 22, 2025

Amphastar Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 177.957M--
Feb 27, 20252024/Q4-- / 188.777M--
Nov 6, 20242024/Q3191.214M / 194.693M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 177.957M--
Feb 27, 20252024/Q4-- / 188.777M--
Nov 6, 20242024/Q3191.214M / 194.693M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--

Unlock Free Earnings Estimates

Amphastar Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 22, 2025

Buy

  • Buy

    33.33%
  • Hold

    66.67%
  • Sell

    0.00%

Price Target

No Data